Skip to main content
. 2020 Sep 29;124(2):425–436. doi: 10.1038/s41416-020-01067-1

Fig. 1. High G3BP1 expression is correlated with poor survival of gastric cancer patients who received adjuvant chemotherapy.

Fig. 1

a G3BP1 IHC scores in gastric cancer and normal tissues (n = 455) from the Zhongshan cohort. The box plot showed the full range of variation (error bars: min and max) with the line representing median. b–d Kaplan–Meier analysis for the overall survival rate of gastric cancer patients from the Zhongshan cohort. b The association of G3BP1 expression with the survival of all patients (n = 455). c The association of G3BP1 expression with the survival of patients receiving adjuvant chemotherapy in stages II–IV (n = 132). d The association of G3BP1 expression with the survival of patients receiving surgery alone in stages II–IV (n = 251). e, f The association of G3BP1 expression with overall survival and progression-free survival of gastric cancer patients receiving adjuvant chemotherapy (e) or surgery alone (f) by analysing the integrated online datasets (GSE14210, GSE15459, GSE22377, GSE29272, GSE51105 and GSE62254) (http://www.kmplot.com/analysis/index.php?p=service&cancer=gastric).